David Moher

844.7k total citations · 81 hit papers
815 papers, 506.2k citations indexed

About

David Moher is a scholar working on Statistics, Probability and Uncertainty, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, David Moher has authored 815 papers receiving a total of 506.2k indexed citations (citations by other indexed papers that have themselves been cited), including 480 papers in Statistics, Probability and Uncertainty, 256 papers in Public Health, Environmental and Occupational Health and 189 papers in Economics and Econometrics. Recurrent topics in David Moher's work include Meta-analysis and systematic reviews (456 papers), Health Systems, Economic Evaluations, Quality of Life (185 papers) and Clinical practice guidelines implementation (103 papers). David Moher is often cited by papers focused on Meta-analysis and systematic reviews (456 papers), Health Systems, Economic Evaluations, Quality of Life (185 papers) and Clinical practice guidelines implementation (103 papers). David Moher collaborates with scholars based in Canada, United Kingdom and United States. David Moher's co-authors include Douglas G. Altman, Jennifer Tetzlaff, Alessandro Liberati, A. Liberati, Kenneth F. Schulz, Peter C Gøtzsche, Mike Clarke, P.J. Devereaux, John P. A. Ioannidis and Cynthia D. Mulrow and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

David Moher

790 papers receiving 496.8k citations

Hit Papers

Preferred reporting items for systematic review... 1995 2026 2005 2015 2009 2009 2009 2009 2011 20.0k 40.0k 60.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
    2009 74.1k citations David Moher, Douglas G. Altman et al. BMJ profile →
  2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
    2009 52.0k citations David Moher, Douglas G. Altman et al. PLoS Medicine profile →
  3. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
    2009 43.1k citations David Moher, Douglas G. Altman et al. profile →
  4. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
    2009 31.2k citations David Moher et al. Annals of Internal Medicine profile →
  5. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
    2011 26.4k citations Julian P. T. Higgins, Doug Altman et al. BMJ profile →
  6. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
    2009 24.4k citations Douglas G. Altman, Peter C Gøtzsche et al. PLoS Medicine profile →
  7. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
    2015 19.5k citations David Moher, Mike Clarke et al. Systematic Reviews profile →
  8. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
    2009 16.2k citations David Moher, Douglas G. Altman et al. Journal of Clinical Epidemiology profile →
  9. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
    2009 14.6k citations Doug Altman, Peter C Gøtzsche et al. BMJ profile →
  10. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
    2010 10.8k citations Kenneth F. Schulz, Douglas G. Altman et al. profile →
  11. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
    2015 9.8k citations David Moher, Mike Clarke et al. BMJ profile →
  12. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    2010 9.7k citations David Moher, Douglas G. Altman et al. profile →
  13. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
    2009 8.8k citations Douglas G. Altman, Peter C Gøtzsche et al. Journal of Clinical Epidemiology profile →
  14. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
    2009 8.4k citations Douglas G. Altman, Peter C Gøtzsche et al. Annals of Internal Medicine profile →
  15. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
    2017 6.7k citations Beverley Shea, Barnaby C Reeves et al. BMJ profile →
  16. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
    2010 6.6k citations David Moher, Sally Hopewell et al. BMJ profile →
  17. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
    2014 6.5k citations Tammy Hoffmann, Paul Glasziou et al. BMJ profile →
  18. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
    2015 5.7k citations Brian Hutton, Ferrán Catalá-López et al. Annals of Internal Medicine profile →
  19. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
    2011 5.5k citations Jonathan A C Sterne, Douglas G. Altman et al. BMJ profile →
  20. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
    2013 4.4k citations An‐Wen Chan, Douglas G. Altman et al. Annals of Internal Medicine profile →
  21. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
    2001 4.2k citations David Moher, Kenneth F. Schulz et al. The Lancet profile →
  22. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
    1999 3.9k citations David Moher et al. The Lancet profile →
  23. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
    2013 3.6k citations A.-W. Chan, Peter C Gøtzsche et al. BMJ profile →
  24. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
    2015 3.4k citations David Moher et al. PLoS Medicine profile →
  25. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
    2007 3.3k citations Beverley Shea, George A. Wells et al. profile →
  26. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
    1998 2.7k citations David Moher, Peter Tugwell et al. The Lancet profile →
  27. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
    2009 2.3k citations Douglas G. Altman, Peter C Gøtzsche et al. profile →
  28. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
    2001 2.3k citations David Moher, Kenneth F. Schulz et al. profile →
  29. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
    2015 2.2k citations Patrick M. Bossuyt, Johannes B. Reitsma et al. BMJ profile →
  30. Scoping reviews: time for clarity in definition, methods, and reporting
    2014 2.0k citations Andrea C. Tricco, David Moher et al. Journal of Clinical Epidemiology profile →
  31. Reprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
    2009 2.0k citations David Moher, Douglas G. Altman et al. profile →
  32. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
    2001 2.0k citations David Moher profile →
  33. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement
    2021 1.8k citations Patrick M. Bossuyt, Isabelle Boutron et al. Journal of Clinical Epidemiology profile →
  34. Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
    2008 1.7k citations Isabelle Boutron, David Moher et al. Annals of Internal Medicine profile →
  35. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
    2010 1.7k citations Kenneth F. Schulz, Douglas G. Altman et al. PLoS Medicine profile →
  36. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
    2011 1.7k citations David Moher, Sally Hopewell et al. profile →
  37. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
    2010 1.6k citations Kenneth F. Schulz, Douglas G. Altman et al. Journal of Pharmacology and Pharmacotherapeutics profile →
  38. A comparison of direct vs. self‐report measures for assessing height, weight and body mass index: a systematic review
    2007 1.6k citations David Moher et al. profile →
  39. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
    2013 1.5k citations David Moher et al. profile →
  40. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
    2010 1.4k citations Kenneth F. Schulz, Douglas G. Altman et al. profile →
  41. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    2013 1.4k citations David Moher et al. BMJ profile →
  42. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
    2010 1.4k citations David Moher, Sally Hopewell et al. Journal of Clinical Epidemiology profile →
  43. Improving the reporting of pragmatic trials: an extension of the CONSORT statement
    2008 1.2k citations Doug Altman, Sean Tunis et al. BMJ profile →
  44. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research
    2017 1.1k citations Doug Altman, David Moher et al. profile →
  45. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
    1995 1.0k citations David Moher, Peter Tugwell et al. profile →
  46. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
    2001 1.0k citations David Moher, Kenneth F. Schulz et al. Annals of Internal Medicine profile →
  47. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement
    2010 1000 citations Douglas G. Altman, David Moher et al. PLoS Medicine profile →
  48. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research
    2017 995 citations Doug Altman, David Moher et al. BMJ profile →
  49. Increasing value and reducing waste in research design, conduct, and analysis
    2014 960 citations David Moher, Kenneth F. Schulz et al. The Lancet profile →
  50. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews
    2012 952 citations Alison Booth, Mike Clarke et al. Systematic Reviews profile →
  51. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
    2015 927 citations Patrick M. Bossuyt, Johannes B. Reitsma et al. profile →
  52. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts
    2017 906 citations Isabelle Boutron, Douglas G. Altman et al. Annals of Internal Medicine profile →
  53. Reporting of Patient-Reported Outcomes in Randomized Trials
    2013 890 citations Jane Blazeby, Douglas G. Altman et al. profile →
  54. A catalogue of reporting guidelines for health research
    2009 890 citations David Moher, Kenneth F. Schulz et al. profile →
  55. Evidence summaries: the evolution of a rapid review approach
    2012 874 citations David Moher et al. Systematic Reviews profile →
  56. The CARE guidelines: consensus-based clinical case reporting guideline development
    2013 856 citations Douglas G. Altman, David Moher et al. profile →
  57. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
    2011 841 citations Kenneth F. Schulz, Douglas G. Altman et al. profile →
  58. Chapter 10: Addressing reporting biases
    2011 839 citations David Moher et al. profile →
  59. Reducing waste from incomplete or unusable reports of biomedical research
    2014 803 citations Paul Glasziou, Douglas G. Altman et al. The Lancet profile →
  60. Guidance for Developers of Health Research Reporting Guidelines
    2010 796 citations David Moher, Kenneth F. Schulz et al. PLoS Medicine profile →
  61. Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials
    2012 768 citations Jelena Savović, Douglas G. Altman et al. Annals of Internal Medicine profile →
  62. A scoping review of rapid review methods
    2015 768 citations Andrea C. Tricco, Brian Hutton et al. profile →
  63. Use of the CONSORT Statement and Quality of Reports of Randomized Trials
    2001 768 citations David Moher et al. profile →
  64. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials
    2010 752 citations Kenneth F. Schulz, Douglas G. Altman et al. Journal of Clinical Epidemiology profile →
  65. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition)
    2009 730 citations David Moher profile →
  66. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
    2015 703 citations Patrick M. Bossuyt, Johannes B. Reitsma et al. profile →
  67. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy.
    2003 674 citations Patrick M. Bossuyt, Johannes B. Reitsma et al. profile →
  68. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review
    2006 626 citations David Moher, Kenneth F. Schulz et al. profile →
  69. Epidemiology and Reporting Characteristics of Systematic Reviews
    2007 624 citations David Moher, Andrea C. Tricco et al. PLoS Medicine profile →
  70. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?
    2000 613 citations Peter Tugwell, David Moher et al. The Lancet profile →
  71. How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis
    2007 555 citations David Moher et al. Annals of Internal Medicine profile →
  72. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals
    2012 531 citations Douglas G. Altman, Laura Weeks et al. profile →
  73. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
    2012 519 citations Jelena Savović, Peter Jüni et al. profile →
  74. Effectiveness and safety of vitamin D in relation to bone health.
    2007 502 citations David Moher et al. profile →
  75. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity
    2012 496 citations Vivian Welch, Mark Petticrew et al. PLoS Medicine profile →
  76. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis
    2012 484 citations Andrea C. Tricco, David Moher et al. The Lancet profile →
  77. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
    2013 481 citations David Moher et al. profile →
  78. An evidence-based practice guideline for the peer review of electronic search strategies
    2009 478 citations David Moher et al. Journal of Clinical Epidemiology profile →
  79. Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study
    2016 476 citations Douglas G. Altman, Andrea C. Tricco et al. PLoS Medicine profile →
  80. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
    2017 468 citations David Moher et al. Systematic Reviews profile →
  81. Preferred reporting items for systematic reviews and meta‐analyses in ecology and evolutionary biology: a PRISMA extension
    2021 384 citations David Moher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Moher Canada 159 87.8k 66.6k 57.3k 54.8k 48.1k 815 506.2k
Douglas G. Altman United Kingdom 220 110.5k 1.3× 73.6k 1.1× 75.4k 1.3× 53.5k 1.0× 65.7k 1.4× 655 618.4k
Jennifer Tetzlaff Canada 30 50.2k 0.6× 32.9k 0.5× 32.2k 0.6× 25.5k 0.5× 28.1k 0.6× 42 273.2k
Peter C Gøtzsche Denmark 74 41.2k 0.5× 25.8k 0.4× 25.8k 0.5× 18.9k 0.3× 23.5k 0.5× 295 204.5k
Matthias Egger Switzerland 134 37.1k 0.4× 25.2k 0.4× 32.9k 0.6× 18.8k 0.3× 20.4k 0.4× 780 212.8k
Alessandro Liberati Italy 41 34.5k 0.4× 24.0k 0.4× 22.3k 0.4× 18.6k 0.3× 19.2k 0.4× 87 193.0k
George Davey Smith United Kingdom 182 23.5k 0.3× 32.5k 0.5× 26.8k 0.5× 20.5k 0.4× 14.4k 0.3× 2.0k 218.3k
Julian P. T. Higgins United Kingdom 118 34.4k 0.4× 18.9k 0.3× 23.9k 0.4× 10.0k 0.2× 23.0k 0.5× 471 205.3k
Gordon Guyatt Canada 192 33.7k 0.4× 24.1k 0.4× 23.0k 0.4× 21.4k 0.4× 29.7k 0.6× 1.4k 174.1k
John P. A. Ioannidis United States 165 25.9k 0.3× 20.6k 0.3× 17.9k 0.3× 13.4k 0.2× 16.1k 0.3× 1.1k 189.3k
Walter C. Willett United States 258 18.9k 0.2× 98.0k 1.5× 20.9k 0.4× 12.0k 0.2× 12.3k 0.3× 1.9k 255.3k

Countries citing papers authored by David Moher

Since Specialization
Citations

This map shows the geographic impact of David Moher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Moher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Moher more than expected).

Fields of papers citing papers by David Moher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Moher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Moher. The network helps show where David Moher may publish in the future.

Co-authorship network of co-authors of David Moher

This figure shows the co-authorship network connecting the top 25 collaborators of David Moher. A scholar is included among the top collaborators of David Moher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Moher. David Moher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bennett, Alexandria, Becky Skidmore, Melissa Brouwers, et al.. (2024). How firearm legislation impacts firearm mortality internationally: A scoping review. SHILAP Revista de lepidopterología. 7. 100127–100127. 2 indexed citations
2.
Beck, Andrew, Alexandria Bennett, Leila Esmaeilisaraji, et al.. (2024). Screening for depression in children and adolescents in primary care or non-mental health settings: a systematic review update. Systematic Reviews. 13(1). 48–48. 7 indexed citations
3.
Uttley, Lesley, Louise Falzon, Jennifer A. Byrne, et al.. (2024). Research culture influences in health and biomedical research: rapid scoping review and content analysis. Journal of Clinical Epidemiology. 178. 111616–111616.
4.
Rethlefsen, Melissa L., Tara Brigham, Carrie Price, et al.. (2023). Systematic review search strategies are poorly reported and not reproducible: a cross-sectional metaresearch study. Journal of Clinical Epidemiology. 166. 111229–111229. 20 indexed citations
5.
Fanelli, Daniele, et al.. (2021). What difference might retractions make? An estimate of the potential epistemic cost of retractions on meta-analyses. Accountability in Research. 29(7). 442–459. 34 indexed citations
6.
Siebert, Maximilian, et al.. (2020). Data-sharing recommendations in biomedical journals and randomised controlled trials: an audit of journals following the ICMJE recommendations. BMJ Open. 10(5). e038887–e038887. 29 indexed citations
7.
Glonti, Ketevan, Daniel Cauchi, Erik Cobo, et al.. (2017). A scoping review protocol on the roles and tasks of peer reviewers in the manuscript review process in biomedical journals. BMJ Open. 7(10). e017468–e017468. 35 indexed citations
8.
Shea, Beverley, Barnaby C Reeves, George A. Wells, et al.. (2017). AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 358. j4008–j4008. 6692 indexed citations breakdown →
9.
Cohen, Jérémie F., Daniël A. Korevaar, Constantine Gatsonis, et al.. (2017). STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference abstracts. BMJ. 358. j3751–j3751. 52 indexed citations
10.
Chauvin, Anthony, David Moher, Doug Altman, et al.. (2017). A protocol of a cross-sectional study evaluating an online tool for early career peer reviewers assessing reports of randomised controlled trials. BMJ Open. 7(9). e017462–e017462. 5 indexed citations
11.
Kirkham, Jamie J, Sarah L. Gorst, Douglas G. Altman, et al.. (2016). Core Outcome Set–STAndards for Reporting: The COS-STAR Statement. PLoS Medicine. 13(10). e1002148–e1002148. 391 indexed citations breakdown →
12.
Hutton, Brian, Ferrán Catalá-López, & David Moher. (2016). La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA. Medicina Clínica. 147(6). 262–266. 421 indexed citations breakdown →
13.
Sarkis‐Onofre, Rafael, Maximiliano Sérgio Cenci, Flávio Fernando Demarco, et al.. (2015). Use of guidelines to improve the quality and transparency of reporting oral health research. Journal of Dentistry. 43(4). 397–404. 54 indexed citations
14.
Hoffmann, Tammy, Paul Glasziou, Isabelle Boutron, et al.. (2014). Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide. UCL Discovery (University College London). 4 indexed citations
15.
Hoffmann, Tammy, Paul Glasziou, Isabelle Boutron, et al.. (2014). Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 348(mar07 3). g1687–g1687. 6536 indexed citations breakdown →
16.
Adams, Denise, Simon Dagenais, Tammy Clifford, et al.. (2013). Complementary and Alternative Medicine Use by Pediatric Specialty Outpatients. PEDIATRICS. 131(2). 225–232. 74 indexed citations
17.
Higgins, Julian P. T., Doug Altman, Peter C Gøtzsche, et al.. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 343(oct18 2). d5928–d5928. 26405 indexed citations breakdown →
18.
Booth, Alison, Mike Clarke, Davina Ghersi, et al.. (2010). An international registry of systematic-review protocols. The Lancet. 377(9760). 108–109. 380 indexed citations
19.
Schulz, Kenneth F., Douglas G. Altman, & David Moher. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. Journal of Pharmacology and Pharmacotherapeutics. 1(2). 100–107. 1610 indexed citations breakdown →
20.
Moher, David, et al.. (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Annals of Internal Medicine. 151(4). 264–269. 31183 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas G. Altman Breakdown of academic impact, for papers by Jennifer Tetzlaff Breakdown of academic impact, for papers by Peter C Gøtzsche Breakdown of academic impact, for papers by Matthias Egger Breakdown of academic impact, for papers by Alessandro Liberati Breakdown of academic impact, for papers by George Davey Smith Breakdown of academic impact, for papers by Julian P. T. Higgins Breakdown of academic impact, for papers by Gordon Guyatt Breakdown of academic impact, for papers by John P. A. Ioannidis Breakdown of academic impact, for papers by Walter C. Willett
Rankless by CCL
2026